(Q51980197)

19 April 2018

title

Population-wide benefits of routine vaccination of children against influenza. (English)

1 reference

19 April 2018

4

Ira M Longini

1 reference

19 April 2018

Betz Halloran

3

object named as

M Elizabeth Halloran

1 reference

19 April 2018

author name string

Derek Weycker

1

1 reference

19 April 2018

John Edelsberg

2

1 reference

19 April 2018

Azhar Nizam

5

1 reference

19 April 2018

Vincent Ciuryla

6

1 reference

19 April 2018

Gerry Oster

7

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 January 2005

1 reference

19 April 2018

published in

Vaccine

1 reference

19 April 2018

volume

23

1 reference

19 April 2018

page(s)

1284-1293

1 reference

19 April 2018

issue

10

1 reference

19 April 2018

Estimates of the US health impact of influenza

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

Health impact of influenza in the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

Mortality associated with influenza and respiratory syncytial virus in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

Acute respiratory illness in the community. Frequency of illness and the agents involved

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

Emerging infections: pandemic influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

Influenzavirus infections in Seattle families, 1975-1979. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

Influenzavirus infections in Seattle families, 1975-1979. I. Study design, methods and the occurrence of infections by time and age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

The Japanese experience with vaccinating schoolchildren against influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

An influenza simulation model for immunization studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

Community interventions and the epidemic prevention potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

Influenza and the rates of hospitalization for respiratory disease among infants and young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

Statistical inference for infectious diseases. Risk-specific household and community transmission parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

A Generalized Stochastic Model for the Analysis of Infectious Disease Final Size Data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

Influenza: its control in persons and populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

Impact of type A influenza on children: a retrospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

Impact of epidemic type A influenza in a defined adult population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

The impact of influenza epidemics on hospitalizations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

The economic impact of pandemic influenza in the United States: priorities for intervention.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

Potential cost savings attributable to influenza vaccination of school-aged children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

Economic impact of influenza vaccination in preschool children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.044

10.1016/J.VACCINE.2004.08.044

7 January 2021

Identifiers

DOI

1 reference

19 April 2018

PubMed ID

15652671

1 reference

19 April 2018